Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Forest Laboratories

Forest Laboratories develops, manufactures and sells both branded and generic forms of ethical products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter, which are used for the treatment of a wide range of illnesses.

Forest products are marketed principally in the United States and western and eastern Europe. Marketing is conducted by Forest and through independent distributors.



In the United States, Forest's ethical specialty products are marketed directly by the Company's Forest Pharmaceuticals, Forest Therapeutics, and Forest Specialty Sales salesforces. The Company's generic products are marketed directly by its Inwood Laboratories, Inc. subsidiary.



In the United Kingdom, Ireland and certain export markets, Forest products are marketed directly by the Company's subsidiaries, Pharmax Limited and the Tosara Group. Pharmax is a U.K. manufacturer and marketer of a range of specialty pharmaceuticals, including products manufactured by Forest and Tosara.


Contact Details:
909 Third Avenue
New York
NY
10022-4731
United States of America
Tel:212 421 7850
Fax:
Email:InvestorRelations@frx.com
WWW:

www.frx.com/




Loading...

Recent Publications by Forest Laboratories:

Effect of position isomerism on the formation and physicochemical properties of pharmaceutical co-crystals.
The effect of position isomerism on the co-crystals formation and...
9th June, 2009
Forest Laboratories, Inc., 49 Mall Drive, Commack, New York 11725. J Pharm Sci. 2009 Jun 5.
DOI Direct Link
Modified-release solid formulations for colonic delivery.
Solid formulations intended for targeted drug release into the lower...
27th March, 2009
Department of Formulation, Pharmaceutical Research & Development, Forest Recent Pat Drug Deliv Formul. 2007;1(1):53-63.
Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
Generalized anxiety disorder (GAD) is a highly prevalent and disabling...
28th February, 2009
Forest Laboratories, Harborside Financial Center, Jersey City, New Jersey, Depress Anxiety. 2008;25(10):854-61.
DOI Direct Link
Drug Safety and Pharmacovigilance--second annual marcus evans conference.
Generalized anxiety disorder (GAD) is a highly prevalent and disabling...
11th July, 2007
Forest Laboratories UK Ltd, Bourne Road, Bexley, Kent, DA5 1NX, UK. IDrugs. 2007 Mar;10(3):165-8.
Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer.
Cancer chemotherapeutic prodrugs, such as the oxazaphosphorines...
28th April, 2006
Forest Research Institute, A Division of Forest Laboratories, Inc., Toxicol In Vitro. 2006 Mar;20(2):176-86. Epub 2005 Nov 15.
DOI Direct Link

View more Forest Laboratories research publications.

Press Releases on Forest Laboratories:

BioPortfolio Logo
Reportlinker Adds Antibiotics - Global Trends 18th November, 2009 Reportlinker
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Antibiotics - Global Trends http://www.reportlinker.com/p0164263
Executives Reveal Secrets to Capitalize on New Developments in Pharmaceutical Marketing Research 11th November, 2009 Pharma Market Research Conference
PARSIPPANY, N.J., Nov. 11 /PRNewswire/ -- Pharma market research thought leaders are discovering new ways to take advantage of the tremendous developments and opportunities in the pharmaceutical
Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 6th November, 2009
PARIS, November 6 /PRNewswire/ -- Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of
Majority of Surveyed Physicians Prescribe Cymbalta and Lyrica for Treatment of Fibromyalgia But Neither Agent Has the Majority of Its Uses in First Line 21st October, 2009 Decision Resources
WALTHAM, Mass., Oct. 21 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that although the
Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech 6th October, 2009 Reportlinker
NEW YORK, Oct. 6 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and

BioNews Results for Forest Laboratories:

Nycomed reports continued satisfactory performance in the third quarter 2009
World Pharma News:  Nov 15 2009 12:42AM Matching: forest laboratories
United Therapeutics a good takeover candidate, analyst says
Gazette.net:  Nov 14 2009 11:14AM Matching: forest laboratories
Nycomed reports continued satisfactory performance in the third quarter 2009
Pharma Live:  Nov 13 2009 3:52AM Matching: forest laboratories
Takeover likely for United, analyst says
Gazette.net:  Nov 13 2009 5:43PM Matching: forest laboratories
Nycomed reports continued satisfactory performance in the third quarter 2009
Therapeutics Daily:  Nov 12 2009 1:48PM Matching: forest laboratories
Promote your company here: BioNewsCast - Press Release Distribution

View more Forest Laboratories news.

Forest Laboratories Clinical Trials:

Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-Release (ER) for Hypertension

Forest Laboratories Patents:

US Patent No.Title
7569605 Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion
4357469 Carrier base material for prolonged release therapeutic compositions
4369172 Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
4389393 Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
4482534 Nitroglycerin preparations

View more Forest Laboratories patents.

Forest Laboratories (FRX) Financial information Links from Barchart

FRX Quote from from Barchart.com
FRX Chart from from Barchart.com
FRX Profile from from Barchart.com
FRX Opinion from from Barchart.com

View more Forest Laboratories finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 668 times since April 2007, the link to the organisation's website has been followed 81 times

Recent Search Terms used to find this page: forest pharma | Forest Laboratories United Kingdom lexapro | non prescriptive armour thyroid from canada | Forest Laboratories official website page | Armour Thyroid AND PenCol | forest labs manufactured in Canada | TOSARA PRODUCTS (U.K.) LIMITED DA5 1NX | Forest Tosara Ltd lundbeck | forest laboratories uk ltd | Forest Laboratories Inc Jersey City NJ fax phone emails | .

Search for more companies in New York

Search for more companies in NY



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Forest Laboratories

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.